Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.
作者信息
Prajna Venkatesh N, Lalitha Prajna S, Mascarenhas Jeena, Krishnan Tiruvengada, Srinivasan Muthiah, Vaitilingam C M, Oldenburg Catherine E, Sy Aileen, Keenan Jeremy David, Porco Travis C, Acharya Nisha R, Lietman Thomas M
出版信息
Br J Ophthalmol. 2012 Nov;96(11):1440-1. doi: 10.1136/bjophthalmol-2012-301825. Epub 2012 Aug 21.
Abstract
摘要
相似文献
1
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.
Br J Ophthalmol. 2012 Nov;96(11):1440-1. doi: 10.1136/bjophthalmol-2012-301825. Epub 2012 Aug 21.
2
Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method.
Curr Eye Res. 2015;40(11):1095-101. doi: 10.3109/02713683.2015.1056802. Epub 2015 Aug 13.
3
Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I.
JAMA Ophthalmol. 2015 Oct;133(10):1210-1. doi: 10.1001/jamaophthalmol.2015.2040.
4
Benefit of polyhexamethylene biguanide in Fusarium keratitis.
Ophthalmic Res. 2012;48(4):171-6. doi: 10.1159/000337140. Epub 2012 Jun 16.
5
Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.
Invest Ophthalmol Vis Sci. 2013 Jun 14;54(6):4167-73. doi: 10.1167/iovs.13-11716.
6
Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
JAMA Ophthalmol. 2017 Jun 1;135(6):520-525. doi: 10.1001/jamaophthalmol.2017.0616.
7
Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis.
Indian J Ophthalmol. 2008 May-Jun;56(3):243-5. doi: 10.4103/0301-4738.40369.
8
Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of and Isolates from Corneal Scrapings.
Biomed Res Int. 2019 Jan 20;2019:6395840. doi: 10.1155/2019/6395840. eCollection 2019.
9
Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Mycoses. 2020 Oct;63(10):1128-1132. doi: 10.1111/myc.13160. Epub 2020 Sep 4.
10
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
JAMA Ophthalmol. 2013 Apr;131(4):422-9. doi: 10.1001/jamaophthalmol.2013.1497.
引用本文的文献
1
kexB Gene Correlates With Aspergillus flavus Keratitis Severity: A Whole-Genome Analysis.
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):42. doi: 10.1167/iovs.66.2.42.
2
Antifungal susceptibility, clinical findings, and biofilm resistance of Fusarium species causing keratitis: a challenge for disease control.
Braz J Microbiol. 2025 Mar;56(1):341-352. doi: 10.1007/s42770-024-01611-8. Epub 2025 Jan 16.
3
Association between in vitro susceptibility and clinical outcomes in fungal keratitis.
J Ophthalmic Inflamm Infect. 2024 Sep 2;14(1):42. doi: 10.1186/s12348-024-00418-w.
4
Fusarium species,Scedosporium species, and Lomentospora prolificans: A systematic review to inform the World Health Organization priority list of fungal pathogens.
Med Mycol. 2024 Jun 27;62(6). doi: 10.1093/mmy/myad128.
5
Keratitis in Taiwan: Molecular Identification, Antifungal Susceptibilities, and Clinical Features.
J Fungi (Basel). 2022 May 3;8(5):476. doi: 10.3390/jof8050476.
6
Keratitis-Review of Current Treatment Possibilities.
J Clin Med. 2021 Nov 23;10(23):5468. doi: 10.3390/jcm10235468.
7
Drug reservoir function of voriconazole impregnated human amniotic membrane: An study.
Indian J Ophthalmol. 2021 May;69(5):1068-1072. doi: 10.4103/ijo.IJO_2649_20.
8
Efficacy of Luliconazole Against Broad-Range Filamentous Fungi Including Fusarium solani Species Complex Causing Fungal Keratitis.
Cornea. 2019 Feb;38(2):238-242. doi: 10.1097/ICO.0000000000001812.
9
Evolution of Practice Patterns for the Treatment of Fungal Keratitis.
JAMA Ophthalmol. 2017 Dec 1;135(12):1448-1449. doi: 10.1001/jamaophthalmol.2017.4763.
10
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. doi: 10.1093/cid/ciw326. Epub 2016 Jun 29.
本文引用的文献
1
Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
Arch Ophthalmol. 2010 Jun;128(6):672-8. doi: 10.1001/archophthalmol.2010.102.
2
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Arch Ophthalmol. 2007 Jun;125(6):789-93. doi: 10.1001/archopht.125.6.789.
3
Voriconazole and fungal keratitis: a report of two treatment failures.
J Ocul Pharmacol Ther. 2006 Dec;22(6):437-9. doi: 10.1089/jop.2006.22.437.
4
In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
Am J Ophthalmol. 2004 May;137(5):820-5. doi: 10.1016/j.ajo.2003.11.078.
5
Current perspectives on ophthalmic mycoses.
Clin Microbiol Rev. 2003 Oct;16(4):730-97. doi: 10.1128/CMR.16.4.730-797.2003.
Zotero 插件